Applied Evidence

What’s new in type 2 diabetes?

Author and Disclosure Information

 

References

CASE JR’s history shows that he is current on his influenza and pneumococcal vaccines. However, he doesn’t recall whether he’s been vaccinated against HBV. Serum testing reveals no previous immunization, and recommending HBV vaccine is appropriate.

Surveillance

The 2012 ADA recommendations do not include any new surveillance practices for microvascular disease. Providers should continue to offer the following screening to T2DM patients annually: urine albumin excretion testing and serum creatinine to assess for nephropathy, a comprehensive dilated eye exam to assess for retinopathy, and a foot exam to assess for distal symmetric polyneuropathy.4

CASE Each of these tests were performed (or ordered) for JR. We’ll see him again in 2 to 3 months for diabetes follow-up.

Acknowledgement

The authors thank Pamela Williams, MD, and Brent Smith, MD, for their guidance in the preparation of this article.

CORRESPONDENCE Jason C. McCarthy, MD, 101 Bodin Circle, Travis Air Force Base, CA 94535; Jason.McCarthy.6@us.af.mil

Pages

Recommended Reading

Canagliflozin Surpasses Sitagliptin as Diabetes Add-On
MDedge Family Medicine
Visceral Fat, Insulin Resistance, Weight Gain Predict Diabetes
MDedge Family Medicine
Seeking Quality in the Cornucopia of New Antidiabetes Drug Classes
MDedge Family Medicine
Psoriasis Plus Diabetes Equals Heightened Vascular Risk
MDedge Family Medicine
Bariatric Surgery May Benefit Extremely Obese Adolescents
MDedge Family Medicine
HbA1c Declines Cut 5-Year Death Rate
MDedge Family Medicine
Insulin Degludec Beats Sitagliptin in Type 2 Diabetes
MDedge Family Medicine
Glucose Excursions Linked to Ventricular Tachycardia
MDedge Family Medicine
Hyaluronidase + Insulin Formulation Cuts Postprandial Glucose Excursions
MDedge Family Medicine
Weight Gain Following Diabetes Diagnosis Boosts Mortality
MDedge Family Medicine